FAAH genetic variation enhances fronto-amygdala function in mouse and human 04 Sep Continue reading →
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors. 04 Sep Continue reading →
A catalytically silent FAAH-1 variant drives anandamide transport in neurons. 28 May Continue reading →
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. 28 May Continue reading →
Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms. 28 May Continue reading →
Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. 28 May Continue reading →